Clinical Trials List
2010-10-01 - 2016-09-30
Phase III
Terminated10
ICD-10E11.610
Type 2 diabetes mellitus with diabetic neuropathic arthropathy
ICD-10E11.618
Type 2 diabetes mellitus with other diabetic arthropathy
ICD-10E11.620
Type 2 diabetes mellitus with diabetic dermatitis
ICD-10E11.621
Type 2 diabetes mellitus with foot ulcer
ICD-10E11.622
Type 2 diabetes mellitus with other skin ulcer
ICD-10E11.628
Type 2 diabetes mellitus with other skin complications
ICD-10E11.630
Type 2 diabetes mellitus with periodontal disease
ICD-10E11.638
Type 2 diabetes mellitus with other oral complications
ICD-10E11.649
Type 2 diabetes mellitus with hypoglycemia without coma
ICD-10E11.65
Type 2 diabetes mellitus with hyperglycemia
ICD-10E11.69
Type 2 diabetes mellitus with other specified complication
ICD-9250.80
Diabetes with other specified manifestations, Type II [non-insulin dependent type][NIDDM type][adult-onset type] or unspecified type, not stated as uncontrolled
-
Trial Applicant
PPD DEVELOPMENT (HK) LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Ye-Hsu Lu Division of Cardiovascular Diseases
- 郭炫孚 Division of Cardiovascular Diseases
- 溫文才 Division of Cardiovascular Diseases
- 朱志生 Division of Cardiovascular Diseases
- 顏學偉 Division of Cardiovascular Diseases
- 鄭凱鴻 Division of Cardiovascular Diseases
- Po-Chao Hsu Division of Cardiovascular Diseases
- Tsung-Hsien Lin Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 陳俊吉 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 楊淵博 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Shih-Sheng Chang Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yi-Heng Li Division of Cardiovascular Diseases
- 李貽恆 Division of Cardiovascular Diseases
- 黃耀毅 Division of Cardiovascular Diseases
- Ping-Yen Liu Division of Cardiovascular Diseases
- 李威廷 Division of Cardiovascular Diseases
- 林志展 Division of Cardiovascular Diseases
- Yen-Wen Liu Division of Cardiovascular Diseases
- Wei-Chuan Tsai Division of Cardiovascular Diseases
- Ting-Hsing Chao Division of Cardiovascular Diseases
- Chih-Hsin Hsu Division of Cardiovascular Diseases
- Cheng-Han Lee Division of Cardiovascular Diseases
- Po-Sheng Chen Division of Cardiovascular Diseases
- Shih-Hung Chan Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- MING-YOW HUNG Division of Cardiovascular Diseases
- AN-TSZ HSIEH Division of Cardiovascular Diseases
- Wen-Rui Hao Division of Cardiovascular Diseases
- LI-CHIN SUNG Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 黃金洲 Division of Endocrinology
- Chin-Sung Kuo Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
60 participants
-
Global
5400 participants
